SS-31 50mg

Performance Profile

• Cardiolipin-Targeted Research: Specifically targets cardiolipin — a key lipid in the inner mitochondrial membrane — making it one of the most selective mitochondrial research compounds currently available.
• ROS Reduction: Significantly reduces reactive oxygen species (ROS) production in cellular oxidative stress models, preventing the mitochondrial damage cascade that ROS overproduction triggers.
• ATP Synthesis Research: Studied for its ability to restore ATP production in mitochondrially compromised cardiac, neuronal, and skeletal muscle cell models.
• Organ-Level Research: Investigated for protective pathway activity across heart, brain, and kidney cell systems in ischemic injury and oxidative stress models.

Quick Summary

• Best For: Mitochondrial dysfunction research, cardiolipin biology, organ-level oxidative stress models.
• Use Case: Restoring mitochondrial membrane efficiency and reducing ROS production in dysfunctional cell models.
• Research Note: Works at the source of mitochondrial dysfunction rather than just neutralising byproducts — mechanistically distinct from general antioxidant compounds.
• Commonly Studied With: NAD+ or MOTS-c — often combined in triple mitochondrial pathway research protocols.

For research purposes only. Not for human consumption. For use by licensed researchers only. These compounds have not been evaluated or approved by Health Canada for human use.